Abstract
Background and purpose Carotid-cavernous fistulas (CCF), dural arteriovenous fistula (DAVF) and spinal arteriovenous fistula (SAVF) are rare vascular malformations that cause arteriovenous shunting. Detecting the shunt point and flow direction is necessary for shunt disease diagnosis and treatment. Hence, we propose a new shunt disease diagnostic way with four dimensional-flow magnetic resonance imaging (4D-flow MRI).
Material and methods The 4D-flow MRI and the DSA (digital subtraction angiography) were performed on 23 patients, including 2 with CCF, 20 with intracranial DAVF, and 1 with SAVF. Catheter embolization was performed in 19 patients. The 4D-flow MRI assessment was conducted for pre- and post-treatment (n = 9), pretreatment only (n = 12) and post-treatment only (n = 2). We use two functions of 4D-flow imaging application, one is a two-dimensional (2D)-colormap, which indicates velocity distribution with color scale for detecting shunt point, and another one is a 2D-flow vector for diagnosing flow direction.
Results Shunt points are detected as red-colored lesions, with higher velocity compared with the surrounded area on 2D-colormap, with corresponding results to DSA findings. A 2D-flow vector indicates flow vectors of the main feeder, drainer, and influenced dural venous sinuses that could complement information obtained from other standard examinations. The post-therapeutic residual shunt flow analysis was consistent with DSA results except for one DAVF case.
Conclusion 2D-colormap helps detect the shunt point of vascular malformations. A 2D-flow vector makes it possible to diagnose CCF, DAVF and SAVF based on flow dynamic analysis. A 4D-flow MRI would be an additional measurement for shunt disease diagnoses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by JSPS KAKENHI Grant Numbers JP21K09098, JP22H03020, and JP22H00190.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study design and protocol have been approved by the ethics committees for human research at our institute, Shiga University of Medical Science (IRB no. R2019-227, R2023-076)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data that support the findings of this study are openly available
Nonstandard Abbreviations and Acronyms
- CCF
- carotid cavernous fistula
- DAVF
- dural arteriovenous fistula
- SAVF
- spinal arteriovenous fistula
- 4D-flow MRI
- four-dimensional-flow magnetic resonance imaging
- DSA
- digital subtraction angiography
- CS
- cavernous sinus
- TS
- transverse sinus
- SS
- sigmoid sinus
- ACF
- anterior cranial fossa
- SR
- sphenoid ridge
- PA
- petrous apex
- VENC
- velocity encoding
- TOF
- time of flight
- DSA
- digital subtraction angiography
- ICA
- internal carotid artery